DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Yeh CN, Chen MH, Chen YY, Yang CY, Yen CC, Tzen CY. et al.
A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17.
Oncotarget 2017;
8: 44121-30
We do not assume any responsibility for the contents of the web pages of other providers.